NYCT £7.35 Per Share, Everyone needs a Covid stock in the portfolio -26 Apr 2020 23:15
Everyone needs a Covid stock in the portfolio, it just really like what Novacyt are doing, they are the real deal in testing for the Novel Coronavirus. It is the quality of the product which sets them apart and why they appeal to health authorities. The big challenge is ramping up manufacturing and production to meet unprecedented demand, getting to 8m production in a couple of months will be big.
Ignore the noise, this product is going to be selling in huge quantity and to the limit of what they can produce for long time.
The revenue figures here are going to be very impressive as updates fall.
The right company at the right time, and for that I see this with 68m shares in issue being a fair price target for me of £7.35, £500m cap. Based on only £25m profit this year thats a p/e of 20, I believe if they get production to 8m tests, say c.£10/test, which would be £80m/month, the profit margin will be very decent on such volume and economies, on sustained demand a profit of £100m is possible, on a p/e of 20 would give £29 per share.
I believe the current share price only values future profit at around £12m, I would easily give it a future projection profit of £25m and £7.35 per share forward p/e as we stand, therefore see value at this level.
DYOR
Gl All